"Hopefully we have a run like they did."
RCPT's stock price was $62.11 (ARNA's approximate current share price) on September 30, 2014 having doubled from $29.01 on June 2, 2014. In late December 2014 RCPT announced the first patient dosing in the RPC1063 Phase III trial and the stock closed the year at $122.51. On March 31, 2015, it's stock price was $164.89. That's what I call a stock price run.
In early July , 2015 RCPT announced it was being acquired for $232/share or $7.2 billion (or $150/share based on ARNA's outstanding common shares number).